KNSA
USDKiniksa Pharmaceuticals International plc Class A Ordinary Shares
$38.755-0.325 (-0.832%)
실시간 가격
Healthcare
Drug Manufacturers - Specialty & Generic
영국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$39.080
고가
$39.220
저가
$38.570
거래량
0.35M
기업 기본 정보
시가총액
2.9B
산업
Drug Manufacturers - Specialty & Generic
국가
United Kingdom
거래 통계
평균 거래량
0.46M
거래소
NMS
통화
USD
52주 범위
저가 $17.82현재가 $38.755고가 $42.05
관련 뉴스
Analyst Upgrades
Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $55
Goldman Sachs analyst Paul Choi maintains Kiniksa Pharmaceuticals with a Buy and raises the price target from $45 to $55.
더 보기
GlobeNewswire
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 - $675 million –– KPL-387 granted Orphan
더 보기
Analyst Upgrades
Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $44
Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals with a Outperform and raises the price target from $38 to $44.
더 보기
